Upon calculating and comparing the odds ratios of the sixteen biomarkers, NGAL emerged as the biomarker with the highest diagnostic odds ratio for CIN, followed by Cystatin-C and uKIM-1. This evidence concerns the gene LCN2 and cervical squamous intraepithelial neoplasia.